• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Accuracy of Xpert MTB/RIF for the detection of tuberculosis and rifampicin-resistance tuberculosis in China: A systematic review and meta-analysis].[Xpert MTB/RIF在中国检测结核病和耐利福平结核病的准确性:一项系统评价和荟萃分析]
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Oct 20;53(2):320-326. doi: 10.19723/j.issn.1671-167X.2021.02.015.
2
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.用于检测成人肺结核及利福平耐药性的Xpert® MTB/RIF检测法
Cochrane Database Syst Rev. 2014 Jan 21;2014(1):CD009593. doi: 10.1002/14651858.CD009593.pub3.
3
Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.用于儿童活动性结核病和利福平耐药性检测的Xpert MTB/RIF和Xpert MTB/RIF Ultra检测方法
Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD013359. doi: 10.1002/14651858.CD013359.pub2.
4
Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.Xpert MTB/RIF 和 Xpert Ultra 检测用于筛查成人肺结核和利福平耐药,无论有无症状。
Cochrane Database Syst Rev. 2021 Mar 23;3(3):CD013694. doi: 10.1002/14651858.CD013694.pub2.
5
Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.Xpert MTB/RIF Ultra 检测和 Xpert MTB/RIF 检测在成人肺外结核和利福平耐药检测中的应用。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD012768. doi: 10.1002/14651858.CD012768.pub3.
6
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.
7
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.用于检测成人肺结核和利福平耐药性的Xpert® MTB/RIF检测
Cochrane Database Syst Rev. 2013 Jan 31(1):CD009593. doi: 10.1002/14651858.CD009593.pub2.
8
Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis.Xpert Ultra 与 Xpert MTB/RIF 检测疑似肺结核成人肺结核和利福平耐药性的比较。
Cochrane Database Syst Rev. 2021 Feb 22;2:CD009593. doi: 10.1002/14651858.CD009593.pub5.
9
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.用于成人肺结核和利福平耐药性检测的Xpert MTB/RIF及Xpert MTB/RIF Ultra检测法
Cochrane Database Syst Rev. 2019 Jun 7;6(6):CD009593. doi: 10.1002/14651858.CD009593.pub4.
10
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.Xpert MTB/XDR 检测系统用于检测肺结核病及异烟肼、氟喹诺酮类、乙胺丁醇和阿米卡星耐药性。
Cochrane Database Syst Rev. 2022 May 18;5(5):CD014841. doi: 10.1002/14651858.CD014841.pub2.

本文引用的文献

1
Feasibility of a new model for early detection of patients with multidrug-resistant tuberculosis in a developed setting of eastern China.在中国东部发达地区建立一种新型耐多药结核病患者早期检测模型的可行性研究
Trop Med Int Health. 2017 Oct;22(10):1328-1333. doi: 10.1111/tmi.12934. Epub 2017 Sep 18.
2
Evaluation of GeneXpert MTB/RIF for detecting Mycobacterium tuberculosis in a hospital in China.在中国一家医院评估GeneXpert MTB/RIF用于检测结核分枝杆菌的情况。
J Int Med Res. 2017 Apr;45(2):816-822. doi: 10.1177/0300060517698618. Epub 2017 Mar 29.
3
Evaluation of GeneXpert MTB/RIF for detection of pulmonary tuberculosis at peripheral tuberculosis clinics.在基层结核病诊所评估GeneXpert MTB/RIF用于检测肺结核的效果。
Microb Pathog. 2017 Apr;105:260-263. doi: 10.1016/j.micpath.2017.02.040. Epub 2017 Feb 28.
4
Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis.中国耐多药结核病(MDR-TB)的疾病负担:一项系统评价与时空分析
BMC Infect Dis. 2017 Jan 10;17(1):57. doi: 10.1186/s12879-016-2151-5.
5
The Abbott RealTime MTB assay and the Cepheid GeneXpert assay show comparable performance for the detection of Mycobacterium tuberculosis in sputum specimens.雅培实时结核菌检测法和赛沛GeneXpert检测法在痰液标本中检测结核分枝杆菌时表现出相当的性能。
Int J Infect Dis. 2016 Apr;45:78-80. doi: 10.1016/j.ijid.2016.02.024. Epub 2016 Mar 3.
6
[A study of the value of three molecular diagnostic techniques in the diagnosis of tuberculosis].[三种分子诊断技术在结核病诊断中的价值研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2015 Sep;38(9):680-5.
7
A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China.中国基层实验室开展Xpert MTB/RIF检测的可行性研究。
Int J Infect Dis. 2015 Feb;31:41-6. doi: 10.1016/j.ijid.2014.09.011. Epub 2014 Oct 30.
8
Evaluation of the Xpert MTB/RIF assay in gastric lavage aspirates for diagnosis of smear-negative childhood pulmonary tuberculosis.评估Xpert MTB/RIF检测在儿童洗胃抽吸物中诊断涂片阴性儿童肺结核的应用。
Pediatr Infect Dis J. 2014 Oct;33(10):1047-51. doi: 10.1097/INF.0000000000000403.
9
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.用于检测成人肺结核和利福平耐药性的Xpert® MTB/RIF检测
Cochrane Database Syst Rev. 2013 Jan 31(1):CD009593. doi: 10.1002/14651858.CD009593.pub2.
10
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.QUADAS-2:用于诊断准确性研究质量评估的修订工具。
Ann Intern Med. 2011 Oct 18;155(8):529-36. doi: 10.7326/0003-4819-155-8-201110180-00009.

[Xpert MTB/RIF在中国检测结核病和耐利福平结核病的准确性:一项系统评价和荟萃分析]

[Accuracy of Xpert MTB/RIF for the detection of tuberculosis and rifampicin-resistance tuberculosis in China: A systematic review and meta-analysis].

作者信息

Feng J N, Gao L, Sun Y X, Yang J C, Deng S W, Sun F, Zhan S Y

机构信息

Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Oct 20;53(2):320-326. doi: 10.19723/j.issn.1671-167X.2021.02.015.

DOI:10.19723/j.issn.1671-167X.2021.02.015
PMID:33879905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8072426/
Abstract

OBJECTIVE

To systematically review the diagnostic accuracy of Xpert /rifampicin (Xpert MTB/RIF) for the detection of active tuberculosis (TB) and rifampicin-resistance TB in Chinese patients.

METHODS

Four Chinese databases (SinoMed, CNKI, WanFang database, and VIP) and three English databases (PubMed, Embase, and The Cochrane Library) were searched from January 1, 2000 to September 15, 2017, to identify diagnostic tests about the accuracy of Xpert MTB/RIF in Chinese patients. Two investigators screened the articles and extracted the information independently, and then the quality of each included study was evaluated by Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2. Bivariate random-effects meta-analysis was conducted to pool the sensitivity and specificity. In addition, subgroup analyses were performed based on patient type (TB patient and TB suspected patient), sample type (sputum, bronchoalveolar lavage fluid and others). All statistical analyses were conducted with Stata version 13.0.

RESULTS

A total of 47 articles were included in this systematic review. Most of them (38 articles) were in Chinese and only 9 articles were in English. All the articles were published during 2014 to 2017, and the sample size ranged from 31 to 3 151. Forty articles including 42 comparisons about TB were finally included with the pooled sensitivity of 0.94 (95%: 0.92, 0.95) and the pooled specificity of 0.87 (95%: 0.84, 0.91). Subgroup analysis showed that different patient and specimen types had no significant differences on sensitivity, but the specificity of sputum group was higher than that of bronchoalveolar lavage fluid. As for the detection of rifampicin-resistant TB, 33 articles (38 comparisons) were analyzed, the pooled sensitivity and specificity were 0.92 (95%: 0.89, 0.94) and 0.98 (95%: 0.97, 0.99) respectively. There were no significant differences between the patient and specimen in the subgroup analyses. The Deeks funnel plot showed a possible publication bias for detecting active tuberculosis (=0.08) and no publication bias for rifampicin-resistant TB (=0.24). The likelihood ratio scatter gram showed that in clinical applications, Xpert MTB/RIF had a good diagnostic ability for detecting active tuberculosis, and it had good clinical diagnostic value in detecting rifampicin-resistant TB.

CONCLUSION

Xpert MTB/RIF has good sensitivity and specificity in detecting TB and rifampicin-resistant TB in Chinese people. In particular, it has good clinical value in diagnosing rifampicin-resistance TB.

摘要

目的

系统评价Xpert/利福平(Xpert MTB/RIF)检测中国患者活动性肺结核(TB)及耐利福平TB的诊断准确性。

方法

检索2000年1月1日至2017年9月15日的四个中文数据库(中国生物医学文献数据库、中国知网、万方数据库和维普资讯网)和三个英文数据库(PubMed、Embase和考克兰图书馆),以识别关于Xpert MTB/RIF在中国患者中诊断准确性的诊断试验。两名研究者独立筛选文章并提取信息,然后采用诊断准确性研究质量评估(QUADAS)-2对每项纳入研究的质量进行评估。进行双变量随机效应荟萃分析以汇总敏感性和特异性。此外,根据患者类型(TB患者和疑似TB患者)、样本类型(痰液、支气管肺泡灌洗液等)进行亚组分析。所有统计分析均使用Stata 13.0版进行。

结果

本系统评价共纳入47篇文章。其中大部分(38篇)为中文,仅9篇为英文。所有文章均发表于2014年至2017年,样本量从31至3151不等。最终纳入40篇文章,其中包括42项关于TB的比较,汇总敏感性为0.94(95%:0.92,0.95),汇总特异性为0.87(95%:0.84,0.91)。亚组分析显示,不同患者和标本类型的敏感性无显著差异,但痰液组的特异性高于支气管肺泡灌洗液组。对于耐利福平TB的检测,分析了33篇文章(38项比较),汇总敏感性和特异性分别为0.92(95%:0.89,0.94)和0.98(95%:0.97,0.99)。亚组分析中患者和标本之间无显著差异。Deeks漏斗图显示检测活动性肺结核可能存在发表偏倚(=0.08),而耐利福平TB不存在发表偏倚(=0.24)。似然比散点图显示,在临床应用中,Xpert MTB/RIF检测活动性肺结核具有良好的诊断能力,在检测耐利福平TB方面具有良好的临床诊断价值。

结论

Xpert MTB/RIF检测中国人TB及耐利福平TB具有良好的敏感性和特异性。特别是在诊断耐利福平TB方面具有良好的临床价值。